Genetic Signatures signs up
Wednesday, 22 October, 2008
Privately held Sydney biotech Human Genetic Signatures has signed a licensing agreement with US diagnostics specialist ProGen Tech to develop assays for pathogens such as MRSA and Clostridium difficile.
The assays will be integrated into ProGen Tech’s Entura nucleic acid purification system.
Human Genetic Signatures’ technology is called 3base, which is designed to simplify the genomes of microbial targets to aid detection. The company has also developed a DNA methylation analysis methodology called MethylEasy.
ProGen Tech hopes to present manual assays to the US FDA next year, followed by a fully automated version in 2010.
The equipment is aimed at the molecular and clinical diagnostics markets.
New targets identified for a universal influenza B vaccine
Researchers have identified fragments from influenza B viruses that the immune system...
Melatonin helps to prevent obesity, studies suggest
In an experiment carried out in rats, chronic administration of melatonin prevented obesity to a...
Personality influences the expression of our genes
An international research team has used artificial intelligence to show that our personalities...
